Grassi Cristina obtained her Master degree in Pharmaceutical Biotechnology at University of Milan (Italy), in June 2023. During her studies, she spent a year in the Department of Pharmaceutical and Biomolecular Sciences at University of Milan led by Professor Patrizia Limonta where she studied prostatic cancer.

In January 2024 she joined the Oncological Endocrinology area of the Lania group, coordinated by Dr. Eleonora Vitali, where she works to find new targets involved in NET progression and in the resistance of pharmacological treatments.